Can Post-Exposure Prophylaxis for COVID-19 Be Considered as an Outbreak Response Strategy in Long-Term Care Hospitals?

Sun Hee Lee; Hyunjin Son; Kyong Ran Peck

Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?

Sun Hee Lee, Hyunjin Son, Kyong Ran Peck

International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105988

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Declarations Funding: No funding. Competing Interests : There are no competing financial interests. Ethical Approval: The study was approved and informed consent was waived by the Institutional Review Board of Pusan National University Hospital (H-2003-014-089). Supplementary materials Supplementary material associated with this article can be found, in the online version, at doi: 10.1016/j.ijantimicag.2020. 105988 .

References

Colson, Rolain, Lagier, Brouqui, Raoult, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents

Colson, Rolain, Raoult, Chloroquine for the 2019 novel coronavirus SARS-CoV-2, Int J Antimicrob Agents

Gao, Tian, Yang, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends

Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents

Jie, He, Xi, Zhi, None

Savarino, Trani, Donatelli, Cauda, Cassone, New insights into the antiviral effects of chloroquine, Lancet Infect Dis

Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res

Yao, Ye, Zhang, Cui, Huang et al., In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquinone for the treatment of severe acute respiratory syndrome coronarvirus 2 (SARS-CoV-2), Clin Infect Dis, doi:10.1093/cid/ciaa237

Zhu, Zhang, Li, Yang, Song, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med

DOI record: { "DOI": "10.1016/j.ijantimicag.2020.105988", "ISSN": [ "0924-8579" ], "URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.105988", "alternative-id": [ "S092485792030145X" ], "article-number": "105988", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Journal of Antimicrobial Agents" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.ijantimicag.2020.105988" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Lee", "given": "Sun Hee", "sequence": "first" }, { "affiliation": [], "family": "Son", "given": "Hyunjin", "sequence": "additional" }, { "affiliation": [], "family": "Peck", "given": "Kyong Ran", "sequence": "additional" } ], "container-title": "International Journal of Antimicrobial Agents", "container-title-short": "International Journal of Antimicrobial Agents", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 4, 17 ] ], "date-time": "2020-04-17T01:34:12Z", "timestamp": 1587087252000 }, "deposited": { "date-parts": [ [ 2020, 6, 23 ] ], "date-time": "2020-06-23T05:02:48Z", "timestamp": 1592888568000 }, "indexed": { "date-parts": [ [ 2024, 5, 13 ] ], "date-time": "2024-05-13T17:15:44Z", "timestamp": 1715620544322 }, "is-referenced-by-count": 51, "issue": "6", "issued": { "date-parts": [ [ 2020, 6 ] ] }, "journal-issue": { "issue": "6", "published-print": { "date-parts": [ [ 2020, 6 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 6, 1 ] ], "date-time": "2020-06-01T00:00:00Z", "timestamp": 1590969600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S092485792030145X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S092485792030145X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "105988", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 6 ] ] }, "published-print": { "date-parts": [ [ 2020, 6 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1056/NEJMoa2001017", "article-title": "A novel coronavirus from patients with pneumonia in China, 2019", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "727", "journal-title": "N Engl J Med", "key": "10.1016/j.ijantimicag.2020.105988_bib0001", "volume": "382", "year": "2020" }, { "DOI": "10.3346/jkms.2020.35.e112", "article-title": "Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020", "doi-asserted-by": "crossref", "first-page": "e112", "journal-title": "J Korean Med Sci", "key": "10.1016/j.ijantimicag.2020.105988_bib0002", "volume": "35", "year": "2020" }, { "DOI": "10.1016/S1473-3099(06)70361-9", "article-title": "New insights into the antiviral effects of chloroquine", "author": "Savarino", "doi-asserted-by": "crossref", "first-page": "67", "journal-title": "Lancet Infect Dis", "key": "10.1016/j.ijantimicag.2020.105988_bib0003", "volume": "6", "year": "2006" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "journal-title": "Cell Res", "key": "10.1016/j.ijantimicag.2020.105988_bib0004", "volume": "30", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquinone for the treatment of severe acute respiratory syndrome coronarvirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "journal-title": "Clin Infect Dis", "key": "10.1016/j.ijantimicag.2020.105988_bib0005", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105923", "article-title": "Chloroquine for the 2019 novel coronavirus SARS-CoV-2", "author": "Colson", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijantimicag.2020.105988_bib0006", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105932", "article-title": "Chloroquine and hydroxychloroquine as available weapons to fight COVID-19", "author": "Colson", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijantimicag.2020.105988_bib0007", "year": "2020" }, { "DOI": "10.5582/bst.2020.01047", "article-title": "Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies", "author": "Gao", "doi-asserted-by": "crossref", "first-page": "72", "journal-title": "Biosci Trends", "key": "10.1016/j.ijantimicag.2020.105988_bib0008", "volume": "14", "year": "2020" }, { "article-title": "[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]", "first-page": "E019", "journal-title": "Zhonghua Jie He He Hu Xi Za Zhi", "key": "10.1016/j.ijantimicag.2020.105988_bib0009", "volume": "43", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "journal-title": "Int J Antimicrob Agents", "key": "10.1016/j.ijantimicag.2020.105988_bib0010", "year": "2020" } ], "reference-count": 10, "references-count": 10, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S092485792030145X" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "55" }